269 related articles for article (PubMed ID: 31928731)
21. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease?
Klein WL
J Alzheimers Dis; 2013; 33 Suppl 1():S49-65. PubMed ID: 22785404
[TBL] [Abstract][Full Text] [Related]
22. Misfolding of amyloidogenic proteins and their interactions with membranes.
Relini A; Marano N; Gliozzi A
Biomolecules; 2013 Dec; 4(1):20-55. PubMed ID: 24970204
[TBL] [Abstract][Full Text] [Related]
23. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.
Celej MS; Sarroukh R; Goormaghtigh E; Fidelio GD; Ruysschaert JM; Raussens V
Biochem J; 2012 May; 443(3):719-26. PubMed ID: 22316405
[TBL] [Abstract][Full Text] [Related]
24. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
Guivernau B; Bonet J; Valls-Comamala V; Bosch-Morató M; Godoy JA; Inestrosa NC; Perálvarez-Marín A; Fernández-Busquets X; Andreu D; Oliva B; Muñoz FJ
J Neurosci; 2016 Nov; 36(46):11693-11703. PubMed ID: 27852777
[TBL] [Abstract][Full Text] [Related]
25. Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates.
Ilie IM; Caflisch A
Chem Rev; 2019 Jun; 119(12):6956-6993. PubMed ID: 30973229
[TBL] [Abstract][Full Text] [Related]
26. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
27. Toxic Amyloid Tape: A Novel Mixed Antiparallel/Parallel β-Sheet Structure Formed by Amyloid β-Protein on GM1 Clusters.
Okada Y; Okubo K; Ikeda K; Yano Y; Hoshino M; Hayashi Y; Kiso Y; Itoh-Watanabe H; Naito A; Matsuzaki K
ACS Chem Neurosci; 2019 Jan; 10(1):563-572. PubMed ID: 30346704
[TBL] [Abstract][Full Text] [Related]
28. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
[TBL] [Abstract][Full Text] [Related]
29. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
30. Early mechanisms of amyloid fibril nucleation in model and disease-related proteins.
Morel B; Conejero-Lara F
Biochim Biophys Acta Proteins Proteom; 2019 Nov; 1867(11):140264. PubMed ID: 31437584
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins.
Guerrero-Muñoz MJ; Castillo-Carranza DL; Kayed R
Biochem Pharmacol; 2014 Apr; 88(4):468-78. PubMed ID: 24406245
[TBL] [Abstract][Full Text] [Related]
32. Study of Protein Amyloid-Like Aggregates by Solid-State Circular Dichroism Spectroscopy.
Hu HY; Jiang LL; Hong JY
Curr Protein Pept Sci; 2017; 18(1):100-103. PubMed ID: 27396751
[TBL] [Abstract][Full Text] [Related]
33. Fullerenol C60(OH)16 prevents amyloid fibrillization of Aβ40-in vitro and in silico approach.
Bednarikova Z; Huy PD; Mocanu MM; Fedunova D; Li MS; Gazova Z
Phys Chem Chem Phys; 2016 Jul; 18(28):18855-67. PubMed ID: 27350395
[TBL] [Abstract][Full Text] [Related]
34. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure.
Goldblatt G; Cilenti L; Matos JO; Lee B; Ciaffone N; Wang QX; Tetard L; Teter K; Tatulian SA
FEBS J; 2017 May; 284(9):1355-1369. PubMed ID: 28294556
[TBL] [Abstract][Full Text] [Related]
35. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
Chang YJ; Chen YR
FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
[TBL] [Abstract][Full Text] [Related]
36. Engineering of a peptide probe for β-amyloid aggregates.
Aoraha E; Candreva J; Kim JR
Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
[TBL] [Abstract][Full Text] [Related]
37. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
Wu WH; Liu Q; Sun X; Yu JS; Zhao DS; Yu YP; Luo JJ; Hu J; Yu ZW; Zhao YF; Li YM
Biochem Biophys Res Commun; 2013 Sep; 439(3):321-6. PubMed ID: 24012671
[TBL] [Abstract][Full Text] [Related]
38. Understanding the Binding Mechanism of Amyloid-β Inhibitors from Molecular Simulations.
Tran L
Curr Pharm Des; 2018; 24(28):3341-3346. PubMed ID: 30101700
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of the hetero-assembly of β-amyloid peptide with islet amyloid polypeptide.
Yan LM; Velkova A; Kapurniotu A
Curr Pharm Des; 2014; 20(8):1182-91. PubMed ID: 23713771
[TBL] [Abstract][Full Text] [Related]
40. The Physiological and Pathological Implications of the Formation of Hydrogels, with a Specific Focus on Amyloid Polypeptides.
Jean L; Foley AC; Vaux DJT
Biomolecules; 2017 Sep; 7(4):. PubMed ID: 28937634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
